Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Avicenna roadmap

The Avicenna Alliance itself has its origins in the Avicenna Roadmap, a 2-year EU funded project, led by DG Connect whose goal was to create a research and technological development Roadmap outlining a strategy for in silico Clinical Trials (ISCT)

Built into the European Commission’s project requirements was a plan to establish a pre-competitive Association - the Avicenna Alliance, that would represent the needs of the in silico medicine community and provide the Commission and other policy makers with expert advice in this field.

The Avicenna Alliance operating since 2016, now works with members to implement this Roadmap and identify policy and regulatory obstacles to the enhancement of in silico medicine.

The Avicenna Alliance is a researcher and industry partnership with 50% membership of the Virtual Physiological Human Initiative (VPH) and 50% representation of the medical devices, pharmaceuticals, software and cosmetics industries.

By engaging both researchers and industry in the conversation on how to roll out this roadmap, the Avicenna Alliance is the one stop shop for all things in silico medicine at EU level.

Click here to find out if you could benefit from Membership of the Avicenna Alliance.

Click here to find more information about the Avicenna Roadmap


Download

NEWS

News Welcome ADSILICO to the Avicenna Alliance!

Welcome ADSILICO to the Avicenna Alliance!

We are delighted to announce that ADSILICO has officially joined the Avicenna Alliance! This partnership marks a significant milestone in our collective mission to advance in silico medicine and foster innovation in healthcare.

News Welcome Bioreme

Welcome Bioreme

We are thrilled to welcome BIOREME (Integrating data-driven BIOphysical models into REspiratory MEdicine), a pioneering collaborative network based in the UK, as Avicenna new Partner!

News Virtual launch of

Virtual launch of "Toward Good Simulation Practice" book

On May 8, 2024, the virtual launch of "Toward Good Simulation Practice: Best Practices for the Use of Computational Modeling and Simulation (CM&S) in the Regulatory Process of Biomedical Products" took place, marking a significant milestone in regulatory science and industry.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry